| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,¶
Departments of
*
Molecular Biology,
Bioregulation Research,
Pathology, Nagoya City University School of Medicine, Nagoya, Japan;
Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan;
¶ Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka-shi, Japan;
|| Department of Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan; and
# Department of Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary
In our earlier results, we demonstrated that cells expressing the complement C5aR are vulnerable since abnormal activation of C5aR caused apoptosis of these cells. In this study, we demonstrate that activation of C5aR by antisense homology box (AHB) peptides synthesized in multiple antigenic peptide form and representing putative interaction sites of the C5a/C5aR evoked calcium influx in TGW neuroblastoma cells. Dose-dependent inhibition of the response was found when the cells were pretreated with C5a, suggesting that C5aR was involved in this process. In addition, pretreatment with monomeric forms of the AHB peptides resulted in attenuation of the calcium signals, supporting the idea of the role of C5aR in this process. Cells of a neuron-rich primary culture and pyramidal cells of rat brain slices also responded to the AHB peptide activation with an increase in the intracellular calcium level, showing that calcium metabolism might be affected in these cells. TUNEL staining demonstrated that C5aR-mediated apoptosis could be induced both in cells of the primary culture as well as in cortical pyramidal neurons of the rat brain. In addition, we investigated expression of C5aR in the hippocampal and cortical neurons of human brains of healthy and demented patients using two anti-human C5aR Abs. Pyramidal cells of the hippocampus and cortex and granular cells of the hippocampus were immunopositive on staining. Although staining was also positive in the vascular dementia brain, it disappeared in the brain with Alzheimer’s disease. These results provide further support that C5aR may be involved in neurodegeneration.
This article has been cited by other articles:
|
|
 |
|
  R. S. Griffin, M. Costigan, G. J. Brenner, C. Him Eddie Ma, J. Scholz, A. Moss, A. J. Allchorne, G. L. Stahl, and C. J. Woolf Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity J. Neurosci., August 8, 2007; 27(32): 8699 - 8708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Woodruff, J. W. Crane, L. M. Proctor, K. M. Buller, A. B. Shek, K. de Vos, S. Pollitt, H. M. Williams, I. A. Shiels, P. N. Monk, et al. Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration FASEB J, July 1, 2006; 20(9): 1407 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Benard, B. J. Gonzalez, M.-T. Schouft, A. Falluel-Morel, D. Vaudry, P. Chan, H. Vaudry, and M. Fontaine Characterization of C3a and C5a Receptors in Rat Cerebellar Granule Neurons during Maturation: NEUROPROTECTIVE EFFECT OF C5a AGAINST APOPTOTIC CELL DEATH J. Biol. Chem., October 15, 2004; 279(42): 43487 - 43496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bergamaschini, E. Rossi, C. Storini, S. Pizzimenti, M. Distaso, C. Perego, A. De Luigi, C. Vergani, and M. Grazia De Simoni Peripheral Treatment with Enoxaparin, a Low Molecular Weight Heparin, Reduces Plaques and {beta}-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease J. Neurosci., April 28, 2004; 24(17): 4181 - 4186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Solforosi, J. R. Criado, D. B. McGavern, S. Wirz, M. Sanchez-Alavez, S. Sugama, L. A. DeGiorgio, B. T. Volpe, E. Wiseman, G. Abalos, et al. Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo Science, March 5, 2004; 303(5663): 1514 - 1516. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
